Epigenetic modulation of doxorubicin resistance and strategies for enhancing chemotherapeutic sensitivity
International Review of Cell and Molecular Biology · 2025
DOI: 10.1016/bs.ircmb.2024.09.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Review of Cell and Molecular Biology, 2025. Verfasst von Sruthi Sritharan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of…. Hauptthemen laut MEDLINE: Doxorubicin, Epigenesis, Genetic, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, SRM Institute of Science and Technology, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil…
Förderung
- Ministry of Science and Technology of the People's Republic of China
- SRM Institute of Science and Technology
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Sritharan, S., & Sivalingam, N. (2025). Epigenetic modulation of doxorubicin resistance and strategies for enhancing chemotherapeutic sensitivity. International Review of Cell and Molecular Biology. https://doi.org/10.1016/bs.ircmb.2024.09.004
Vancouver
Sritharan S, Sivalingam N. Epigenetic modulation of doxorubicin resistance and strategies for enhancing chemotherapeutic sensitivity. International Review of Cell and Molecular Biology. 2025. doi:10.1016/bs.ircmb.2024.09.004
BibTeX
@article{Sritharan2025,
author = {Sritharan, Sruthi and Sivalingam, Nageswaran},
title = {Epigenetic modulation of doxorubicin resistance and strategies for enhancing chemotherapeutic sensitivity},
journal = {International Review of Cell and Molecular Biology},
year = {2025},
doi = {10.1016/bs.ircmb.2024.09.004}
}
EUVIMED